Opportunity Information: Apply for CDC RFA GH12 1205
Apply for CDC RFA GH12 1205
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Establishment of an expanded Caribbean HIV/AIDS monitoring and evaluation technical assistance unit within the Caribbean Health Research Council (CHRC) under the Presidents Emergency Plan for AIDS Relief (PEPFAR" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Feb 2, 2012 and posted on Feb 2, 2012.
- Applicants must submit their applications by Apr 2, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,200,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $400,000.00 in funding.
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- The Caribbean Health Research Council was assigned responsibility for coordinating the scale up of HIV/AIDS monitoring and evaluation in the Caribbean by the Pan Caribbean Partnership Against HIV/AIDS (PANCAP), a special project of CARICOM. PANCAP Member Countries are Anguilla, Antigua Barbuda, The Bahamas, Barbados, Belize, Bermuda, British Virgin Islands, Cayman Islands, Cuba, Dominica, Dominican Republic, Grenada, Guyana, Haiti, Jamaica, Montserrat, Netherlands Antilles, Puerto Rico, St. Kitts Nevis, St., Lucia, St. Vincent The Grenadine, Suriname, Trinidad Tobago, Turks Caicos Islands, and the US Virgin Islands.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity (Funding Opportunity Number CDC RFA GH12-1205) was a Centers for Disease Control and Prevention (CDC) cooperative agreement released under the Presidents Emergency Plan for AIDS Relief (PEPFAR) to support the Establishment of an expanded Caribbean HIV/AIDS monitoring and evaluation technical assistance unit within the Caribbean Health Research Council (CHRC). The overall aim was to strengthen HIV/AIDS monitoring and evaluation (M&E) capacity across the Caribbean so that national and regional HIV leaders, program managers, and frontline staff could more effectively design M&E approaches, collect higher-quality data, analyze and interpret results, and routinely use strategic information to guide policy and program decisions. In practical terms, the opportunity focused on improving how HIV programs track performance, demonstrate results, prioritize interventions, and ensure accountability for resources through stronger data systems and consistent use of evidence.
The program was positioned as regional technical assistance, with CHRC serving as the hub for scaling up HIV/AIDS M&E in partnership with the Pan Caribbean Partnership Against HIV/AIDS (PANCAP), a CARICOM special project. CHRC had already been assigned responsibility for coordinating the regional scale-up of HIV/AIDS M&E by PANCAP, and this funding opportunity was designed to expand that function into a more robust technical assistance unit. The geographic scope covered PANCAP member countries and territories across the Caribbean, including Anguilla, Antigua and Barbuda, The Bahamas, Barbados, Belize, Bermuda, the British Virgin Islands, the Cayman Islands, Cuba, Dominica, the Dominican Republic, Grenada, Guyana, Haiti, Jamaica, Montserrat, the Netherlands Antilles, Puerto Rico, St. Kitts and Nevis, St. Lucia, St. Vincent and the Grenadines, Suriname, Trinidad and Tobago, the Turks and Caicos Islands, and the U.S. Virgin Islands. By structuring the effort around a regional body and a regional partnership, the opportunity emphasized shared standards, coordinated support, and comparable performance tracking across multiple national HIV responses.
Because the funding instrument was a cooperative agreement, the expectation was not simply pass-through funding but active collaboration between CDC and the awardees in implementing the work. Cooperative agreements typically indicate substantial federal involvement, such as jointly shaping technical approaches, aligning M&E methods with PEPFAR expectations, and ensuring that monitoring, reporting, and strategic information products meet established quality standards. The activity category was health, and the CFDA number was 93.067 (Global AIDS), reinforcing that the work was part of the broader U.S. government global HIV/AIDS portfolio.
The opportunity anticipated up to three awards, with an estimated total funding amount of $1,200,000 and an award ceiling of $400,000. There was no cost-sharing or matching requirement, meaning applicants were not required to contribute additional non-federal funds as a condition of award. The announcement was posted on February 2, 2012, with an original and final closing date of April 2, 2012, and it was archived on May 2, 2012. These details point to a time-limited competition intended to quickly stand up or expand capacity for M&E technical assistance in the region.
Eligibility was described as "Others (see text field entitled Additional Information on Eligibility for clarification)," with the narrative emphasizing CHRCs designated role from PANCAP to coordinate the Caribbean scale-up of HIV/AIDS M&E. The framing signals that the funding was closely aligned to CHRCs regional mandate and that applicants would need to fit within, or credibly support, that coordination function. In effect, the competition was aimed at ensuring that the technical assistance unit anchored at CHRC could deliver consistent, region-wide support to national AIDS programs and implementing partners.
At the heart of the project was strengthening the full cycle of M&E and strategic information use. That includes building the capacity to design M&E strategies (deciding what indicators to track, how data should flow, and what tools and processes are required), improving data collection (quality, completeness, timeliness, and standardization), advancing analytic capacity (turning raw counts into meaningful trends, coverage estimates, performance dashboards, and interpretations), and institutionalizing data use (ensuring leaders and managers actually apply findings to set priorities, adjust programs, and justify budgets). The description also stresses documentation of results and accountability for resources, which aligns with PEPFARs emphasis on demonstrating outcomes, tracking program performance, and ensuring that funds support measurable public health impact. In a regional context, this kind of M&E strengthening can also support comparability across countries and territories, facilitate shared learning, and help identify where targeted support is most needed.
For applicants or stakeholders who had difficulty accessing the full announcement, the listed point of contact was CDC PGOTIMS, reachable by phone at 770-488-2700 or by email at pgotim@cdc.gov.
Frequently Asked Questions (FAQs)
What is the funding opportunity number for this grant?
The funding opportunity number is CDC RFA GH12-1205.
Which U.S. agency released this grant opportunity?
The opportunity was released by the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism is used for this opportunity?
This opportunity uses a cooperative agreement, which generally means CDC is expected to have substantial involvement in the work (for example, collaborating on technical approaches and aligning monitoring and reporting with expectations).
How is this opportunity connected to PEPFAR?
The cooperative agreement was released under the President's Emergency Plan for AIDS Relief (PEPFAR) and is part of the broader U.S. government global HIV/AIDS portfolio.
What is the primary purpose of this cooperative agreement?
The purpose is to support the establishment of an expanded Caribbean HIV/AIDS monitoring and evaluation (M&E) technical assistance unit within the Caribbean Health Research Council (CHRC).
What is the overall aim of the project?
The overall aim is to strengthen HIV/AIDS monitoring and evaluation capacity across the Caribbean so national and regional HIV leaders, program managers, and frontline staff can better design M&E approaches, collect higher-quality data, analyze and interpret results, and use strategic information to guide policy and program decisions.
What does the opportunity mean by "monitoring and evaluation (M&E)" strengthening?
Based on the description, M&E strengthening includes improving the full cycle of M&E and strategic information use: designing M&E strategies (such as indicators, data flow, and tools), improving data collection (quality, completeness, timeliness, and standardization), strengthening analysis and interpretation (trends, coverage estimates, dashboards), and institutionalizing routine data use for decision-making and accountability.
What practical outcomes was the program trying to improve?
In practical terms, the program focused on improving how HIV programs track performance, demonstrate results, prioritize interventions, and ensure accountability for resources by strengthening data systems and consistently using evidence to guide decisions.
What organization was intended to serve as the hub for this work?
The Caribbean Health Research Council (CHRC) was positioned to serve as the regional hub for scaling up HIV/AIDS M&E technical assistance.
How does PANCAP fit into the program structure?
The effort was framed as regional technical assistance with CHRC as the hub, working in partnership with the Pan Caribbean Partnership Against HIV/AIDS (PANCAP), which is a CARICOM special project.
Why was CHRC specifically highlighted in the eligibility framing?
The narrative notes that CHRC had already been assigned responsibility by PANCAP for coordinating the regional scale-up of HIV/AIDS M&E. The funding opportunity was designed to expand that function into a more robust technical assistance unit, signaling alignment with CHRC's designated regional coordination role.
What region and countries/territories were included in the geographic scope?
The geographic scope covered PANCAP member countries and territories across the Caribbean, including: Anguilla, Antigua and Barbuda, The Bahamas, Barbados, Belize, Bermuda, the British Virgin Islands, the Cayman Islands, Cuba, Dominica, the Dominican Republic, Grenada, Guyana, Haiti, Jamaica, Montserrat, the Netherlands Antilles, Puerto Rico, St. Kitts and Nevis, St. Lucia, St. Vincent and the Grenadines, Suriname, Trinidad and Tobago, the Turks and Caicos Islands, and the U.S. Virgin Islands.
How many awards were anticipated?
The opportunity anticipated up to three awards.
What was the estimated total funding amount for the opportunity?
The estimated total funding amount was $1,200,000.
What was the award ceiling per award?
The award ceiling was $400,000.
Was cost sharing or matching required?
No. The opportunity stated there was no cost-sharing or matching requirement.
What was the activity category?
The activity category was health.
What CFDA number was associated with this opportunity?
The CFDA number was 93.067 (Global AIDS).
When was the announcement posted?
The announcement was posted on February 2, 2012.
What were the application closing dates?
The original and final closing date was April 2, 2012.
When was the opportunity archived?
The opportunity was archived on May 2, 2012.
What did the eligibility category say?
Eligibility was listed as "Others (see text field entitled Additional Information on Eligibility for clarification)."
What does the eligibility language suggest about who the opportunity was aimed at?
Based on the narrative provided, the opportunity appears closely aligned with CHRC's regional mandate through PANCAP to coordinate the Caribbean scale-up of HIV/AIDS M&E, implying applicants would need to fit within, or credibly support, that coordination function.
Why does the opportunity emphasize a regional approach instead of only country-by-country support?
The description emphasizes shared standards, coordinated support, and comparable performance tracking across multiple national HIV responses, using a regional body (CHRC) and regional partnership (PANCAP) to support consistency and shared learning across countries and territories.
What kinds of beneficiaries were expected to gain capacity from this work?
The description identifies national and regional HIV leaders, program managers, and frontline staff as key audiences for improved M&E capacity and strategic information use.
What does "substantial federal involvement" imply in this cooperative agreement?
It implies active collaboration between CDC and awardees in implementing the work, such as jointly shaping technical approaches, aligning M&E methods with PEPFAR expectations, and ensuring monitoring, reporting, and strategic information products meet quality standards.
Who was the point of contact for questions or access issues?
The listed point of contact was CDC PGOTIMS.
How could CDC PGOTIMS be reached?
They could be reached by phone at 770-488-2700 or by email at pgotim@cdc.gov.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21)
Previous opportunity: Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH12 1205
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH12 1205) also looked into and applied for these:
| Funding Opportunity |
|---|
| Planning Grant The Money Follows the Person Rebalancing Demonstration Program Apply for CMS 1LI 12 001 Funding Number: CMS 1LI 12 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $200,000 |
| Expanding Participation of People with Disabilities in USAID Activities andStrengthen the Capacities of Disabled Peoples Organizations (DPOs) Apply for RFA 114 12 000002 Funding Number: RFA 114 12 000002 Agency: Georgia USAID Tbilisi Category: Health Funding Amount: $600,000 |
| Implementation of a Program to Build the Institutional Apply for CDC RFA GH12 1243 Funding Number: CDC RFA GH12 1243 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,130,000 |
| Modeling Social Behavior (R01) Apply for RFA GM 13 006 Funding Number: RFA GM 13 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Grand Challenges in Global Mental Health Integrating Mental Health into Chronic Disease Care Provision in Low and Middle Income Countries (R01) Apply for RFA MH 13 040 Funding Number: RFA MH 13 040 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Increasing Human Resources for Health and Epidemiological Capacity in the Republic of Guyana through a University Training Program under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1208 Funding Number: CDC RFA GH12 1208 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $440,000 |
| Sober Truth on Preventing Underage Drinking Act Grants Apply for SP 12 003 Funding Number: SP 12 003 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $50,000 |
| Improving Quality of Care and Health Impact through Sustainable, Integrated, Innovative Information System Technologies in Malawi under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1250 Funding Number: CDC RFA GH12 1250 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $8,000,000 |
| Ancillary Studies in PREDICT HD (U01) Apply for PAR 12 097 Funding Number: PAR 12 097 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ancillary Domain Validation Patient Reported Outcomes Measurement Information System (PROMIS) Studies (R01) Apply for RFA AR 12 007 Funding Number: RFA AR 12 007 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| National Forum for State and Territorial Chief Executives Apply for HRSA 12 152 Funding Number: HRSA 12 152 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Reduce the Incidence and Mitigate the Impact of HIV/AIDS in Mali under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1231 Funding Number: CDC RFA GH12 1231 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Technical Assistance to The Ministry of Health (MOH) for HIV Services and Program Transition in Zambezia Province of the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1224 Funding Number: CDC RFA GH12 1224 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $25,000,000 |
| Stem Cell Approaches to Developing New Therapies for Ocular Diseases (R01) Apply for RFA EY 12 001 Funding Number: RFA EY 12 001 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Strong Start for Mothers and Newborns Apply for CMS 1D1 12 001 Funding Number: CMS 1D1 12 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: Case Dependent |
| Development of a Laboratory Network and Society to Implement a Quality Systems Improvement Program Toward Accreditation and Laboratory Management under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1201 Funding Number: CDC RFA GH12 1201 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $6,000,000 |
| Money Follows the Person Rebalancing Grant Demonstration Apply for CMS 1LI 13 001 Funding Number: CMS 1LI 13 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: Case Dependent |
| Initiatives to Educate State Officials and Policy Makers about Priority Public Health Issues Related to the Prevention and Control of STDs and HIV/AIDS, NCHHSTP Apply for CDC RFA PS11 111802CONT12 Funding Number: CDC RFA PS11 111802CONT12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Development of Measures to Determine Successful Hearing Health Care Outcomes (R01) Apply for PAR 12 101 Funding Number: PAR 12 101 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| CDC NCAR Joint Resident Postdoctoral Fellowship Training Program in Public Health Climate Science Apply for CDC RFA CK12 1204 Funding Number: CDC RFA CK12 1204 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH12 1205", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.